Fast Track Biomedical Engineering Technology Co op - Ingeniería Biomédica
Biomedical engineers address healthcare problems from a unique perspective, blending an understanding of biomedical science with specialist knowledge of engineering techniques and problem solving skills.
You will focus on human systems, the design and operation of devices and processes and the application of engineering skills to new medical treatments, instruments and machines.
Our reputation for biomedical innovation in areas such as developing the bionic ear and eye, and targeted drug delivery systems, ensures you are learning from leaders in the field, who are working on exciting projects aimed at solving major health dilemmas.
The Master of Engineering (Biomedical) will provide you with a formal qualification in biomedical engineering at the Masters level.
One of the following undergraduate degrees with a Bioengineering Systems major or sequence:
with a weighted average mark of at least H3 (65%).
All students studying at the University of Melbourne must satisfy the University’s English language entry requirements. For graduate entry, Engineering offers an alternative.
Year 1 (Prelim)
Biomechanical Physics and Computation
Introduction to Biomechanics
Circuits and Systems
Engineering Communication and Practice
Clinical Trials and Regulations
Electrical Network Analysis & Design
Anatomy and Physiology for Engineers
Biomedical Engineering Research Project
Biomedical Engineering Management
Biomedical Engineering Design Project
Biomedical engineers develop new drug therapies, study the electrical and mechanical activity of organs such as the brain, heart and muscle, build artificial organs, limbs, heart valves and bionic implants to replace lost function, and grow living tissues to replace failing organs.
You can expect to work in the biotechnology, biomedical, pharmaceutical, medical device and equipment industries, in research and innovation, in the health services, hospitals, or in government and consulting, and for companies such as Cochlear, Sanofi, Cell Therapies, Compumedics, Ausbiotech and GlaxoSmithKline.